Therlinsie Fleurizard, MD
Orthopaedic Surgery · Frederick, MDNPI 1407241664
Payments from drug & device makers
Across 87 payments — averaging $315.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Supreme Orthopedic Systems, LLC$5K
- Zimmer Biomet$5K
- Microport Orthopedics Inc$4K
- Stryker$2K
- Encore Medical, LP$1K
- plus $747 from 7 others
What the payments were for
- Travel & lodging$8,31330%
- Food & beverage$4,72917%
- Education$14,44953%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $10,117 |
| Supreme Orthopedic Systems, LLC | 5 | $4,761 |
| Zimmer Biomet | 14 | $4,666 |
| Microport Orthopedics Inc | 17 | $4,209 |
| Stryker | 16 | $1,691 |
| Encore Medical, LP | 16 | $1,301 |
| Abbott | 2 | $300 |
| Medical Device Business Services, Inc. | 5 | $146 |
| Nevro Corp. | 4 | $137 |
| Medtronic | 1 | $56 |
| Johnson & Johnson(2 entities) | 2 | $46 |
| Olympus America Inc. | 1 | $32 |
| Boston Scientific | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MPO Medial Pivot Knee$3,882
- ROSA$1,172
- MAKO$1,168
- Persona$862
- DJO Surgical TaperFill Hip System$573
- DJO SURGICAL$440
- PROCLAIM$300
- TAPESTRY$120
- Journey II BCS$117
- Anthology$117
- DJO Surgical 3DKnee System$114
- DJO Surgical CLP Hip System$114
- DJO Surgical Cobalt HV Bone Cement$114
- Omnia$108
How this compares
$27,491 in reported general payments places this provider in the 80th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 66 | $926 |
| Meloxicam | 93 | $400 |
| Gabapentin | 47 | $223 |
| Methylprednisolone | 28 | $215 |
| Oxycodone Hcl | 38 | $173 |
| Tramadol Hcl | 57 | $117 |
| Methocarbamol | 20 | $91 |
| Clindamycin Hcl | 17 | $91 |
| Amoxicillin | 38 | $56 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Frederick
- David GwinnFrederick$33K
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$8.1M
- Anand MurthiBaltimore$5.4M
- Timothy CoddTowson$3.7M
- Khaled KebaishBaltimore$3.5M
- Hamid HassanzadehBethesda$2M
- Michael AinLutherville$1.6M
- Paul SponsellerBaltimore$1.5M
- Shawn StandardBaltimore$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.